Motco increased its position in shares of CVS Health Corp (NYSE:CVS) by 3.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 54,525 shares of the pharmacy operator’s stock after purchasing an additional 1,580 shares during the quarter. Motco’s holdings in CVS Health were worth $4,434,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Horan Capital Advisors LLC. raised its stake in CVS Health by 3.2% during the second quarter. Horan Capital Advisors LLC. now owns 32,115 shares of the pharmacy operator’s stock worth $2,584,000 after acquiring an additional 1,000 shares in the last quarter. Community Bank N.A. raised its stake in CVS Health by 7.3% during the second quarter. Community Bank N.A. now owns 19,976 shares of the pharmacy operator’s stock worth $1,608,000 after acquiring an additional 1,362 shares in the last quarter. FIL Ltd raised its stake in CVS Health by 13.8% during the second quarter. FIL Ltd now owns 514,836 shares of the pharmacy operator’s stock worth $41,424,000 after acquiring an additional 62,318 shares in the last quarter. Midwest Investment Management LLC raised its stake in CVS Health by 6.2% during the second quarter. Midwest Investment Management LLC now owns 21,382 shares of the pharmacy operator’s stock worth $1,720,000 after acquiring an additional 1,245 shares in the last quarter. Finally, ETRADE Capital Management LLC raised its stake in CVS Health by 3.7% during the second quarter. ETRADE Capital Management LLC now owns 55,653 shares of the pharmacy operator’s stock worth $4,478,000 after acquiring an additional 1,979 shares in the last quarter. 81.69% of the stock is owned by institutional investors and hedge funds.
In related news, EVP Lisa Bisaccia sold 29,445 shares of the company’s stock in a transaction that occurred on Thursday, December 21st. The stock was sold at an average price of $75.00, for a total value of $2,208,375.00. Following the sale, the executive vice president now directly owns 15,556 shares in the company, valued at $1,166,700. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.61% of the company’s stock.
Several research analysts have commented on CVS shares. Robert W. Baird reissued a “hold” rating and set a $77.00 target price on shares of CVS Health in a research note on Friday, October 27th. Needham & Company LLC raised CVS Health from a “hold” rating to a “buy” rating and boosted their target price for the stock from $69.02 to $79.00 in a research note on Friday, November 10th. Deutsche Bank reaffirmed a “hold” rating on shares of CVS Health in a research note on Tuesday, December 5th. Mizuho set a $90.00 price objective on CVS Health and gave the company a “buy” rating in a research note on Tuesday, October 24th. Finally, Raymond James Financial reaffirmed a “buy” rating on shares of CVS Health in a research note on Monday, December 4th. Two analysts have rated the stock with a sell rating, eight have issued a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company’s stock. CVS Health has an average rating of “Buy” and a consensus target price of $87.25.
CVS Health Corp (CVS) opened at $79.86 on Friday. CVS Health Corp has a 52 week low of $66.45 and a 52 week high of $84.00. The stock has a market capitalization of $80,900.00, a P/E ratio of 16.50, a PEG ratio of 1.25 and a beta of 0.90. The company has a quick ratio of 0.55, a current ratio of 1.05 and a debt-to-equity ratio of 0.67.
CVS Health (NYSE:CVS) last announced its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.01. CVS Health had a return on equity of 16.96% and a net margin of 2.77%. The business had revenue of $46.18 billion for the quarter, compared to analysts’ expectations of $46.17 billion. During the same period in the prior year, the business posted $1.64 earnings per share. The firm’s revenue was up 3.5% on a year-over-year basis. analysts expect that CVS Health Corp will post 5.89 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, February 2nd. Investors of record on Wednesday, January 24th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.50%. The ex-dividend date is Tuesday, January 23rd. CVS Health’s payout ratio is presently 41.32%.
ILLEGAL ACTIVITY WARNING: This article was first published by TrueBlueTribune and is owned by of TrueBlueTribune. If you are reading this article on another website, it was illegally stolen and reposted in violation of international trademark & copyright laws. The legal version of this article can be accessed at https://www.truebluetribune.com/2018/01/20/cvs-health-corp-cvs-position-raised-by-motco.html.
CVS Health Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.